BridgeMD
New treatment option for type1diabetes
Official title Diabetes in African Youth
ClinicalTrials.gov ID: NCT05454176
What this study is testing
- What it's testing
- This RCT aims to improve T1D care in East African children and young adults by testing the hypothesis that enabling patients to continuously monitor glucose levels with flash CGM technology will improve glucose time-in-range (glucose level 70-180 mg/dl). A second primary endpoint is to perform a cost analysis on flash glucose monitoring compared to 3x/day SMBG, to determine whether this technology is cost-effective in the setting of a less-resourced nation.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 26
You may be able to join if
- Children and youth in Uganda, age 4-26 years at the beginning of the baseline assessment
- T1D (determined by clinical criteria, as autoantibody testing is not regionally available) of at least 12 months duration at the beginning of the...
- Receiving insulin therapy
- Access to a cell phone (nearly ubiquitous in Uganda, even in remote areas)
- At least one parent or guardian (or as per local regulations) is present in clinic and able to give consent for children under 18 years of age (those...
You likely can't join if
- Unwilling or unable to be seen monthly at the pediatric diabetes clinic
- Pregnant or breast-feeding; women likely to become pregnant in the next year
- Major medical conditions which the investigator feels would interfere with study participation
- Patient already has CGM
- Inability during the baseline assessment period to wear the sensor for at least 7 days or return it
- Participant deemed unlikely or unable to comply with the protocol
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 26 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.